Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Neonatal Netw ; 43(4): 224-233, 2024 08 01.
Article in English | MEDLINE | ID: mdl-39164095

ABSTRACT

The controversial topic of oral feeding while on noninvasive ventilation remains at the forefront of preterm intensive care management. The intersection of pulmonary, neurologic, and gastrointestinal maturation coalesces at a postmenstrual age that requires changes in practices compared with those used in older infants. Various animal models in the past decades aimed to gain physiological knowledge of noninvasive ventilation effects on the suck-swallow-breathe coordination sequence. However, the preterm infant poses nuanced anatomic challenges. Although concerns for oral feeding while on noninvasive ventilation include aspiration risks and potential inpatient obstacles, there is evidence to support the feasibility, initiation, and progression of oral feedings while an infant is supported on high-flow nasal cannula and continuous positive airway pressure. There is evidence to support that this may accelerate attainment of oral feeding milestones and, thus, eventual hospital discharge. More recent multidisciplinary institutional protocols may provide cautious guidance on evaluation and algorithms to assess infants who may benefit from initiation and advancement of oral feeding versus awaiting further maturation.


Subject(s)
Bottle Feeding , Infant, Premature , Noninvasive Ventilation , Humans , Infant, Newborn , Noninvasive Ventilation/methods , Bottle Feeding/methods
2.
Clin J Pain ; 29(7): 623-4, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23328335

ABSTRACT

BACKGROUND: Prescription opioid diversion and abuse are becoming increasingly prevalent in many regions of the world, particularly the United States. One method advocated to assess compliance with opioid prescriptions is occasional "pill counts." Shortly before a scheduled appointment, a patient is notified that they must bring in the unused portion of their opioid prescription. It has been assumed that if a patient has the correct number and strength of pills that should be present for that point in a prescription interval that they are unlikely to be selling or abusing their opioids. METHODS: Two cases are presented where patients describe short term rental of opioids from illicit opioid dealers in order to circumvent pill counts. RESULTS: Pill renting appears to be an established method of circumventing pill counts. CONCLUSIONS: Pill counts do not assure non-diversion of opioids and provide additional cash flow to illicit opioid dealers.


Subject(s)
Analgesics, Opioid/adverse effects , Analgesics, Opioid/therapeutic use , Medication Adherence , Opioid-Related Disorders/diagnosis , Opioid-Related Disorders/prevention & control , Prescription Drug Diversion/prevention & control , Substance Abuse Detection/methods , Adult , Entrepreneurship , Female , Humans , Male , Middle Aged , Opioid-Related Disorders/etiology , Prescriptions
3.
J Rehabil Res Dev ; 39(2): 211-24, 2002.
Article in English | MEDLINE | ID: mdl-12051465

ABSTRACT

Fatigue is a very common symptom of multiple sclerosis (MS). Theoretically, fatigue may be related to neuromodulation by soluble products of the autoimmune process or by disruption of central nervous system pathways necessary for sustained activity, but little empirical evidence supports these possibilities. Amantadine, pemoline, and modafanil improved fatigue in placebo-controlled clinical trials, but these studies all had significant limitations. Difficulty measuring fatigue has impeded studies of its characteristics, mechanisms, and therapeutics. Most studies have relied on self-report questionnaires. These may be inappropriate, however, because they can be easily confounded by other symptoms of MS, they are entirely subjective, and they require patients to make difficult retrospective assessments. Studies of fatigue would be improved by including measures of more rigorously defined, quantifiable components of fatigue. For example, motor fatigue can be measured as the decline in strength during sustained muscle contractions. Cognitive fatigue can be measured as the analogous decline in cognitive performance during tasks requiring sustained attention. Lassitude is defined as a subjective sense of reduced energy, and it can be measured with the use of a visual analog diary. These measures provide reproducible results and demonstrate significant differences between MS patients and healthy controls. Dividing fatigue into these components can provide objective assessments that are less likely to be confounded by other symptoms of MS, such as weakness, spasticity, cognitive impairment, and depressed mood.


Subject(s)
Fatigue/etiology , Fatigue/therapy , Multiple Sclerosis/complications , Muscle Fatigue , Evidence-Based Medicine/methods , Fatigue/physiopathology , Female , Humans , Male , Multiple Sclerosis/diagnosis , Prognosis , Risk Assessment , Risk Factors , Severity of Illness Index , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL